IGFBP3 and breast cancer: Given that the ADIPOQ rs7649121 SNP was associated with the IGFBP-3 serum concentration it is not possible to disentangle if the modifying effect was due to a breast cancer signaling pathway or to the effect of the SNP on the IGFBP-3 serum concentration.